How to assess breast cancer risk in menopausal patients being treated with menopausal hormone therapy? [0.03%]
绝经期患者接受绝经过渡期激素治疗的男性乳腺癌风险评估方法是什么？
Serge Rozenberg,Chloé Taelman,Jean Vandromme et al.
Serge Rozenberg et al.
Introduction: The administration of Menopausal Hormone Therapy (MHT) needs to be evaluated in relation to the individual patient's indications for therapy and risk estimations, which include the Breast Cancer (BC) risk es...
Sarcopenic obesity: pathogenesis, epidemiology and management in older adults [0.03%]
sarcopenic肥胖症：发病机制、流行病学及老年人的治疗管理
Costas Glavas,David Scott
Costas Glavas
Introduction: Sarcopenic obesity is the confluence of low skeletal muscle mass and function with excess adiposity. Sarcopenic obesity is becoming increasingly prevalent among older adults and may contribute to greater ris...
Implications of the era of incretin-based weight loss therapy in menopause [0.03%]
GLP-1受体激动剂应用于绝经期减重的启示
Santiago Palacios
Santiago Palacios
Rhea Sibal,G Balamurugan,Yitka Graham et al.
Rhea Sibal et al.
Introduction: Obesity is a chronic, progressive, and heterogeneous disease defined by excess adiposity that impairs health. While Body Mass Index (BMI) remains the most used diagnostic tool, it is increasingly regarded as...
De-escalation, palliation and end of life care in frail older people with diabetes-a critical review [0.03%]
糖尿病脆弱老年人的减量治疗、姑息治疗和临终关怀——批判性综述
I Siqueira,J Jenkinson,P Briggs et al.
I Siqueira et al.
Introduction: Frail older people with diabetes will need regular medications review and individualized care, especially at the final phase of life. Although guidelines are detailed on escalation of medications, there is l...
Association of thyroid function within the normal range with glycemic control and cardiovascular risk factors in type 1 diabetes [0.03%]
在1型糖尿病患者中，甲状腺功能正常范围内的变化与血糖控制和心血管危险因素的关系
Mariana Lourenço,Ana Rita Leite,Patrícia Ferreira et al.
Mariana Lourenço et al.
Background: Thyroid hormone (TH) variations, even within the normal range, influence cardiometabolic health. In type 1 diabetes (T1D), optimizing glycemic control and cardiovascular risk is crucial to prevent complication...
Prediabetes phenotypes: can aetiology and risk profile guide lifestyle strategies for diabetes prevention? [0.03%]
糖尿病前期表型：病因和风险因素能引导生活方式干预以预防糖尿病吗？
Sally D Poppitt,Jennifer Miles-Chan,Marta P Silvestre
Sally D Poppitt
Introduction: Type 2 diabetes (T2D) continues to worsen globally alongside rise in obesity. Asymptomatic dysglycaemia, which precedes T2D, provides opportunities to identify those at risk and target prevention but prediab...
Digenic, oligogenic and genetic modifiers in disorders/differences of sex development (DSD) [0.03%]
性发育 disorder/difference（DSD）中的双基因、寡基因和遗传修饰因子
Ken McElreavey,Maeva Elzaiat,Anu Bashamboo
Ken McElreavey
How do we balance metabolic surgery and emerging incretin-based medical therapies for type 2 diabetes? [0.03%]
如何在代谢手术和新型胰高血糖素样肽-1受体激动剂治疗之间寻找2型糖尿病患者的平衡点？
Hamayle Saeed,Mary Elizabeth Patti
Hamayle Saeed
Differential metabolic responses to very-low calorie diets in individuals with, and without type 2 diabetes: a review [0.03%]
糖尿病患者和非糖尿病患者对极低热量饮食的代谢反应差异：综述
Oluwaseun Anyiam,Iskandar Idris
Oluwaseun Anyiam
Introduction: Very-low calorie-diets (VLCD) are becoming increasingly popular for managing overweight, obesity and type 2 diabetes (T2D). Beta-cell dysfunction and insulin resistance (IR) is present in individuals living ...